NSCLC patients exhibit aberrant expression of DM-specific microbial dysbiosis markers (CRP, LBP, CD14), implicating microbiota-derived endotoxemia in lung carcinogenesis (Qian et al., 2022). The gene discussed is CD14; the disease is diabetes mellitus.